We use cookies for a better user experience. Read our Privacy Policy

I Agree

Allergy relieving Eye Drops Market

Allergy relieving Eye Drops Market (Drug Class - Antihistamines, Non-steroidal anti-Inflammatory Drugs, Vasoconstrictors; Type - Seasonal and Perennial Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis; Distribution Channel - Hospital Pharmacies, Retail, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Allergy-relieving Eye Drops Market - Snapshot

The global allergy-relieving eye drops market is expected to reach a value of US$ 1,930.3 Mn by the end of 2026, expanding at a significant CAGR of 5.0% during the forecast period. Increase in prevalence and incidence rates of eye-related disorders, high unmet needs in patients with ocular allergy, increased geriatric population, raised awareness about eye diseases in developing countries are expected to boost the allergy-relieving eye drops market during the forecast period. Moreover, significant rise in incidence of eye-related diseases, especially in developed countries, is anticipated to drive the allergy-relieving eye drops market between 2018 and 2026. According to the Prevent Blindness Report, the number of people in the U.S. suffering from cataract is expected to increase from 24.4 Mn in 2010, to 30.5 Mn by 2020, and the number of people suffering from diabetic retinopathy in the U.S. is projected to rise from 7.7 Mn in 2010 to reach 9.2 Mn by 2020

The global allergy-relieving eye drops market has been segmented based on drug class, type, distribution channel, and region. In terms of drug class, the global market has been classified into antihistamines, non-steroidal anti-inflammatory drugs, vasoconstrictors, and others. The antihistamines segment dominates the allergy-relieving eye drops market, in terms of value. The wide acceptance of antihistamines as the first line of treatment for allergic conjunctivitis is likely to drive the segment. Furthermore, increase in the prevalence of allergic conjunctivitis and rise in awareness about eye-related disorders are anticipated to propel the segment during the forecast period. This segment is also expected to expand at a significant CAGR, owing to its effectiveness in the treatment of ocular allergy. The vasoconstrictors segment follows the antihistamines segment, in terms of share, of the global allergy-relieving eye drops market. The dominance of the segment is attributed to the extensive utilization of vasoconstrictors to relieve redness of the eyes associated with ocular allergy.

allergy-relieving-eye-drops-market.jpg

In terms of type, the global market has been classified into seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, giant papillary conjunctivitis, and others. The seasonal and perennial allergic conjunctivitis segment is likely to dominate the global allergy-relieving eye drops market during the forecast period.

In terms of distribution channel, the allergy-relieving eye drops market has been segregated into hospital pharmacies, retail, and online sales. The retail segment held a major share of the market in 2017, followed by hospital pharmacies. The retail segment is expected to maintain its market share during forecast period due to the availability of both prescription as well as OTC drugs for allergic conjunctivitis. The online pharmacies segment is projected to expand at a considerable CAGR during the forecast period, owing to easy availability of drugs at home at a discounted price and long-term treatment required for certain form of ocular allergies.

In terms of region, the allergy-relieving eye drops market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the allergy-relieving eye drops market, owing to the high awareness about minor eye-related disorders in the U.S. and increased prevalence of allergic conjunctivitis in the region. Moreover, North America is anticipated to be a highly attractive market for allergy-relieving eye drops during the forecast period, owing to the high cost of prescription drugs and a significant number of people in this region covered by medical insurance.

Major players operating in the allergy-relieving eye drops market include Allergan Plc., Johnson & Johnson Services, Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd. Key players are expanding their product portfolios through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical companies, which is expected to increase the product availability and thereby boost the market.

Rising Prevalence of Eye Infections Worldwide to Propel Growth of Allergy Relieving Eye Drops Market

Increasing prevalence and occurrence paces of eye-related issues, high neglected requirements in patients with visual allergy, expanded geriatric populace, brought issues to light about eye sicknesses in agricultural nations are relied upon to support the allergy-relieving eye drops market during the conjecture time frame. Also, critical ascent in rate of eye-related sicknesses, particularly in created nations, is expected to drive the allergy-relieving eye drops market.

The wide acknowledgment of antihistamines as the main line of treatment for hypersensitive conjunctivitis is probably going to drive the antihistamines section of this market. Moreover, expansion in the pervasiveness of hypersensitive conjunctivitis and ascend in mindfulness about eye-related problems are expected to impel the portion during the gauge time frame. This fragment is likewise expected to grow at a huge CAGR, attributable to its adequacy in the treatment of visual allergy. The vasoconstrictors section follows the antihistamines fragment, as far as offer, of the worldwide allergy-relieving eye drops market. The predominance of the fragment is credited to the broad usage of vasoconstrictors to alleviate redness of the eyes related with visual allergy.

The rapidly expanding geriatric populace is inclined to huge danger of eye-related issues, including visual deficiency. Public mindfulness with respect to regular eye conditions is expanding in non-industrial nations, prompting early analysis and treatment of eye illnesses. Besides, countless associations are committed to battle visual impairment, reestablish vision, and make mindfulness with respect to eye wellbeing. Critical ascent in frequency of eye-related infections, particularly in created nations, is expected to drive this market.

Geographically, North America rules the allergy-relieving eye drops market, attributable to the high mindfulness about minor eye-related issues in the U.S. furthermore, expanded predominance of unfavorably susceptible conjunctivitis around there. Besides, North America is expected to be a profoundly alluring business sector for allergy-free eye drops during the gauge time frame, inferable from the significant expense of physician endorsed drugs and a critical number of individuals in this district covered by clinical protection.

The global allergy-relieving eye drops market has been segmented as below:

Drug Class

  • Antihistamines
  • Non-steroidal anti-Inflammatory Drugs
  • Vasoconstrictors
  • Others

Type

  • Seasonal and Perennial Allergic Conjunctivitis
  • Vernal Keratoconjunctivitis
  • Atopic Keratoconjunctivitis
  • Giant Papillary Conjunctivitis
  • Others

Distribution Channel

 

  • Hospital Pharmacies
  • Retail
  • Online Sales

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa
Allergy relieving Eye Drops Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy-relieving Eye Drops Market

4. Market Overview
     4.1. Introduction
            4.1.1. Market Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Allergy-relieving Eye Drops Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis

5. Market Outlook
     5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
     5.2. Pipeline Analysis
     5.3. Regulatory Scenario by Region

6. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Drug Class
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
            6.3.1. Antihistamines
            6.3.2. Non-steroidal Anti-inflammatory Drugs
            6.3.3. Vasoconstrictors
            6.3.4. Others
     6.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Drug Class

7. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Type
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
            7.3.1. Seasonal and Perennial Allergic Conjunctivitis
            7.3.2. Vernal Keratoconjunctivitis
            7.3.3. Atopic Keratoconjunctivitis
            7.3.4. Giant Papillary Conjunctivitis
            7.3.5. Others
     7.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Type

8. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Distribution Channel
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
            8.3.1. Hospital Pharmacies
            8.3.2. Retail
            8.3.3. Online Sales
     8.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel

9. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Region
     9.1. Key Findings
     9.2. Global Allergy-relieving Eye Drops Market Value Forecast, by Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East & Africa
     9.3. Global Allergy-relieving Eye Drops Market Attractiveness, by Country/Region

10. North America Allergy-relieving Eye Drops Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. North America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
            10.2.1. Antihistamines
            10.2.2. Non-steroidal Anti-inflammatory Drugs
            10.2.3. Vasoconstrictors
            10.2.4. Others
     10.3. North America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
            10.3.1. Seasonal and Perennial Allergic Conjunctivitis
            10.3.2. Vernal Keratoconjunctivitis
            10.3.3. Atopic Keratoconjunctivitis
            10.3.4. Giant Papillary Conjunctivitis
            10.3.5. Others
     10.4. North America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
            10.4.1. Hospital Pharmacies
            10.4.2. Retail
            10.4.3. Online Sales
     10.5. North America Allergy-relieving Eye Drops Market Value Forecast, by Country, 2016–2026
            10.5.1. US
            10.5.2. Canada
     10.6. North America Allergy-relieving Eye Drops Market Attractiveness Analysis
            10.6.1. By Drug Class
            10.6.2. By Type
            10.6.3. By Distribution Channel
            10.6.4. By Country

11. Europe Allergy-relieving Eye Drops Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Europe Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
            11.2.1. Antihistamines
            11.2.2. Non-steroidal Anti-inflammatory Drugs
            11.2.3. Vasoconstrictors
            11.2.4. Others
     11.3. Europe Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
            11.3.1. Seasonal and Perennial Allergic Conjunctivitis
            11.3.2. Vernal Keratoconjunctivitis
            11.3.3. Atopic Keratoconjunctivitis
            11.3.4. Giant Papillary Conjunctivitis
            11.3.5. Others
     11.4. Europe Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
            11.4.1. Hospital Pharmacies
            11.4.2. Retail
            11.4.3. Online Sales
     11.5. Europe Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
            11.5.1. Germany
            11.5.2. France
            11.5.3. U.K.
            11.5.4. Italy
            11.5.5. Spain
            11.5.6. Rest of Europe
     11.6. Europe Allergy-relieving Eye Drops Market Attractiveness Analysis
            11.6.1. By Drug Class
            11.6.2. By Type
            11.6.3. By Distribution Channel
            11.6.4. By Country/Sub-region

12. Asia Pacific Allergy-relieving Eye Drops Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
            12.2.1. Antihistamines
            12.2.2. Non-steroidal Anti-inflammatory Drugs
            12.2.3. Vasoconstrictors
            12.2.4. Others
     12.3. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
            12.3.1. Seasonal and Perennial Allergic Conjunctivitis
            12.3.2. Vernal Keratoconjunctivitis
            12.3.3. Atopic Keratoconjunctivitis
            12.3.4. Giant Papillary Conjunctivitis
            12.3.5. Others
     12.4. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
            12.4.1. Hospital Pharmacies
            12.4.2. Retail
            12.4.3. Online Sales
     12.5. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
            12.5.1. Japan
            12.5.2. China
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
     12.6. Asia Pacific Allergy-relieving Eye Drops Market Attractiveness Analysis
            12.6.1. By Drug Class
            12.6.2. By Type
            12.6.3. By Distribution Channel
            12.6.4. By Country/Sub-region

13. Latin America Allergy-relieving Eye Drops Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
            13.2.1. Antihistamines
            13.2.2. Non-steroidal Anti-inflammatory Drugs
            13.2.3. Vasoconstrictors
            13.2.4. Others
     13.3. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
            13.3.1. Seasonal and Perennial Allergic Conjunctivitis
            13.3.2. Vernal Keratoconjunctivitis
            13.3.3. Atopic Keratoconjunctivitis
            13.3.4. Giant Papillary Conjunctivitis
            13.3.5. Others
     13.4. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
            13.4.1. Hospital Pharmacies
            13.4.2. Retail
            13.4.3. Online Sales
     13.5. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
     13.6. Latin America Allergy-relieving Eye Drops Market Attractiveness Analysis
            13.6.1. By Drug Class
            13.6.2. By Type
            13.6.3. By Distribution Channel
            13.6.4. By Country/Sub-region

14. Middle East & Africa Allergy-relieving Eye Drops Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
            14.2.1. Antihistamines
            14.2.2. Non-steroidal Anti-inflammatory Drugs
            14.2.3. Vasoconstrictors
            14.2.4. Others
     14.3. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
            14.3.1. Seasonal and Perennial Allergic Conjunctivitis
            14.3.2. Vernal Keratoconjunctivitis
            14.3.3. Atopic Keratoconjunctivitis
            14.3.4. Giant Papillary Conjunctivitis
            14.3.5. Others
     14.4. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
            14.4.1. Hospital Pharmacies
            14.4.2. Retail
            14.4.3. Online Sales
     14.5. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region 2016–2026
            14.5.1. GCC Countries
            14.5.2. Israel
            14.5.3. South Africa
            14.5.4. Rest of MEA
     14.6. Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness Analysis
            14.6.1. By Drug Class
            14.6.2. By Type
            14.6.3. By Distribution Channel
            14.6.4. By Country/Sub-region

15. Competition Landscape
     15.1. Global Allergy-relieving Eye Drops Market Share Analysis, by Company (2016)
     15.2. Company Profiles
            15.2.1. Allergan plc.
                     15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.2.1.2. Product Portfolio
                     15.2.1.3. SWOT Analysis
                     15.2.1.4. Financial Overview
                     15.2.1.5. Strategic Overview
            15.2.2. Novartis AG
                     15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.2.2.2. Product Portfolio
                     15.2.2.3. SWOT Analysis
                     15.2.2.4. Financial Overview
                     15.2.2.5. Strategic Overview
            15.2.3. Johnson & Johnson Services, Inc.
                     15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.2.3.2. Product Portfolio
                     15.2.3.3. SWOT Analysis
                     15.2.3.4. Financial Overview
                     15.2.3.5. Strategic Overview
            15.2.4. Pfizer, Inc.
                     15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.2.4.2. Product Portfolio
                     15.2.4.3. SWOT Analysis
                     15.2.4.4. Financial Overview
                     15.2.4.5. Strategic Overview
            15.2.5. F. Hoffmann-La Roche Ltd.
                     15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.2.5.2. Product Portfolio
                     15.2.5.3. SWOT Analysis
                     15.2.5.4. Financial Overview
                     15.2.5.5. Strategic Overview
            15.2.6. Bausch Health Companies Inc.
                     15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.2.6.2. Product Portfolio
                     15.2.6.3. SWOT Analysis
                     15.2.6.4. Financial Overview
                     15.2.6.5. Strategic Overview
            15.2.7. Regeneron Pharmaceuticals, Inc.
                     15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.2.7.2. Product Portfolio
                     15.2.7.3. SWOT Analysis
                     15.2.7.4. Financial Overview
                     15.2.7.5. Strategic Overview
            15.2.8. Santen Pharmaceutical Co., Ltd.
                     15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     15.2.8.2. Product Portfolio
                     15.2.8.3. SWOT Analysis
                     15.2.8.4. Financial Overview
                     15.2.8.5. Strategic Overview

List of Tables

Table 01: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 02: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 03: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 04: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 07: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 08: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 09: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 10: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 11: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 12: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 13: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 15: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 16: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 17: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 19: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 20: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 21: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 23: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 24: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026

List of Figures

Figure 01: Global Allergy-relieving Eye Drops Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
Figure 02: Global Allergy-relieving Eye Drops Market Revenue, by Drug Class, 2018(E) 
Figure 04: Global Allergy-relieving Eye Drops Market Revenue Share
Figure 05: Global Allergy-relieving Eye Drops Market Revenue Share
Figure 06: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 07: Global Allergy-relieving Eye Drops Market Value Share, by Type (2017)
Figure 08: Global Allergy-relieving Eye Drops Market Value Share, by Distribution Channel (2017)
Figure 09: Global Allergy-relieving Eye Drops Market Value Share, by Region (2017)
Figure 10: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Drug Class, 2018 and 2026
Figure 11: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antihistamines, 2016–2026
Figure 12: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Non-steroidal Anti-inflammatory Drugs, 2016–2026
Figure 13: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vasoconstrictors, 2016–2026
Figure 14: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 15: Global Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 16: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 17: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Seasonal and Perennial Allergic Conjunctivitis, 2016–2026
Figure 18: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vernal Keratoconjunctivitis, 2016–2026
Figure 19: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Atopic Keratoconjunctivitis, 2016–2026
Figure 20: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Giant Papillary Conjunctivitis, 2016–2026
Figure 21: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 22: Global Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 23: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Distribution Channel, 2018 and 2026
Figure 24: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2016–2026
Figure 25: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail, 2016–2026
Figure 26: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Sales, 2016–2026
Figure 27: Global Allergy-relieving Eye Drops Market Attractiveness Analysis, by Distribution Channel
Figure 28: Global Allergy-relieving Eye Drops Market Value Share (%), by Region, 2018 and 2026
Figure 29: Global Allergy-relieving Eye Drops Market Attractiveness, by Region, 2018–2026
Figure 30: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 31: North America Allergy-relieving Eye Drops Market Attractiveness, by Country, 2018–2026
Figure 32: North America Allergy-relieving Eye Drops Market Value Share, by Country, 2017 and 2026
Figure 33: North America Allergy-relieving Eye Drops Market Value Share, by  Drug Class, 2017 and 2026
Figure 34: North America Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 35: North America Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 36: North America Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 37: North America Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 38: North America Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 39: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 40: Europe Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-Region, 2018–2026
Figure 41: Europe Allergy-relieving Eye Drops Market Value Share, by Country/Sub-Region, 2017 and 2026
Figure 42: Europe Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
Figure 43: Europe Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 44: Europe Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 45: Europe Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 46: Europe Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 47: Europe Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 48: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 49: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 50: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 51: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by  Drug Class, 2017 and 2026
Figure 52: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 53: Asia Pacific Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 54: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 55: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 56: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 57: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 58: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 59: Latin America Allergy-relieving Eye Drops Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 60: Latin America Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
Figure 61: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 62: Latin America Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 63: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 64: Latin America Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 65: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 66: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 67: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-Region, 2018–2026
Figure 68: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Country/Sub-Region, 2017 and 2026
Figure 69: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
Figure 70: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 71: Middle East & Africa Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 72: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 73: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 74: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 75: Allergan plc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
Figure 76: Allergen plc. R&D Expenses (USD Mn), 2016–2017
Figure 77: Allergan plc. Sales and Marketing Expenses (USD Mn), 2017
Figure 78: Allergan plc. Breakdown of Net Sales, by Business Segment, 2017
Figure 79 : Johnson & Johnson Services, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 80: Johnson & Johnson Services, Inc. Vision care revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2017
Figure 81: Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 82: Johnson & Johnson Services, Inc.(Research & Development Cost, 2015 – 2017 (US$ Bn)
Figure 83: Pfizer, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 84: Pfizer, Inc. R&D Expenses and SI&A Expenses (%) 2015–2017
Figure 85: Pfizer, Inc. Breakdown of Net Sales, by Geography (Essential Health Segment), 2017
Figure 86: Pfizer, Inc. Breakdown of Net Sales, by Business Segments (%), 2017
Figure 87: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Business Segment, 2017
Figure 88: F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 89: F. Hoffmann-La Roche Ltd. Research & Development Cost, 2015 – 2017 (US$ Bn)
Figure 90: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 91: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 92: Novartis AG Breakdown of Net Sales, by Region, 2017
Figure 93: Novartis AG Breakdown of Net Sales, by Business Segments, 2017
Figure 94: Bausch Health Companies Inc. Breakdown of Net Sales (%), by Region, 2017
Figure 95: Bausch Health Companies Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
Figure 96: Bausch Health Companies Inc. Breakdown of Revenues(%), by Product Category, 2017
Figure 97: Bausch Health Companies Inc. R&D Expenses (US$ Mn), 2015-2017
Figure 98: Regeneron Pharmaceuticals, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 99: Regeneron Pharmaceuticals, Inc. R&D Expenses (US$ Mn), 2013-2017
Figure 100: Santen Pharmaceutical Co., Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 101: Santen Pharmaceutical Co., Ltd. Breakdown of Net Sales, by Operating Segments, 2017
Figure 102: Santen Pharmaceutical Co., Ltd. Breakdown of Net Sales, by Region, 2017
Figure 103: Santen Pharmaceutical Co., Ltd. Research & Development Cost, 2015–2017 (US$ Mn)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

800

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved